T cell responses to SARS-CoV-2 spike cross-recognize OmicronRoanne Keeton, Catherine Riou, Linda‐Gail Bekker et al.|Nature|2022Cited by 623
Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b studyGlenda Gray, James G. Kublin, Mary Allen et al.|The Lancet Infectious Diseases|2011Cited by 385
International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populationsDan H. Barouch, Jaap Goudsmit, Sandra V. Kik et al.|Vaccine|2011Cited by 308
Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120–MF59 in AdultsGlenda Gray, Lubbe Wiesner, Linda‐Gail Bekker et al.|New England Journal of Medicine|2021Cited by 231
Microbial Composition Predicts Genital Tract Inflammation and Persistent Bacterial Vaginosis in South African Adolescent FemalesKatie Lennard, Heather B. Jaspan, Smritee Dabee et al.|Infection and Immunity|2017Cited by 179